Management of stage II colon cancer - the use of molecular biomarkers for adjuvant therapy decision

Overview of attention for article published in BMC Gastroenterology, February 2013

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

patent: 1 patent

Citations

dimensions_citation: 50 Dimensions

Readers on

mendeley: 59 Mendeley

Summary Patents Dimensions citations

So far, Dimensions has found 50 publications that cite this research output.

50

The most recent citing publications are shown below. View all 50 publications that cite this research output on Dimensions.

Protein prognostic biomarkers in stage II colorectal cancer: implications for post-operative management

Article in BJC Reports (February 2024)

From complexity to clarity: unravelling tumor heterogeneity through the lens of tumor microenvironment for innovative cancer therapy

Article in Histochemistry and Cell Biology (January 2024)

Stage III deficient mismatch repair colon patients get greater benefit from earlier starting oxaliplatin-based chemotherapy regimen

Article in Scientific Reports (June 2023)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.